{
  "timestamp": "2025-04-19 14:54:53",
  "phase": "Evolution",
  "round": 3,
  "elo_score": null,
  "content": "*Key changes:* Focuses on *distinct mutational signatures* for risk profiling; adds feasibility via accessible tissues.  \n*Supporting evidence:* [Preston 2007]; [Goode 2002]; [Alexandrov 2013].\n\n---"
}